Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Harvey Branton"'
Publikováno v:
Engineering Biology, Vol 7, Iss 1-4, Pp 1-17 (2023)
Abstract Cell‐Free Protein Synthesis (CFPS) has, over the past decade, seen a substantial increase in interest from both academia and industry. Applications range from fundamental research, through high‐throughput screening to niche manufacture o
Externí odkaz:
https://doaj.org/article/f852b6bbb5c845049eb3c3910e749f8f
Autor:
Jonathan Jones, Didier Kindembe, Harvey Branton, Najib Lawal, Eduardo Lopez Montero, John Mack, Shuo Shi, Ron Patton, Gary Montague
Publikováno v:
Food and Bioproducts Processing. 138:209-220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d73121f2ad2f39e074d5bf3498836dac
https://doi.org/10.1016/j.fbp.2023.02.004
https://doi.org/10.1016/j.fbp.2023.02.004
Autor:
Daniel P Myatt, Lewis Wharram, Charlotte Graham, John Liddell, Harvey Branton, Claire Pizzey, Nathan Cowieson, Robert Rambo, Robin J Shattock
Publikováno v:
Biology Methods and Protocols. 8
The current SARS-Covid-2 (SARS-CoV-2) pandemic has led to an acceleration of messenger ribonucleic acid (mRNA) vaccine technology. The development of production processes for these large mRNA molecules, especially self-amplifying mRNA (saRNA), has re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4281469f5eb33e2b309023ddaabbc8bd
https://doi.org/10.1093/biomethods/bpad001
https://doi.org/10.1093/biomethods/bpad001
Autor:
Daniel P Myatt, Lewis Wharram, Charlotte Graham, John Liddell, Harvey Branton, Claire Pizzey, Nathan Cowieson, Robert Rambo, Robin J Shattock
The current SARS-Covid-2 pandemic has led to an acceleration of messenger – ribonucleic acid (mRNA) vaccine technology. The development of production processes for these large mRNA molecules, especially self-amplifying mRNA (saRNA) has required con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::307e657cb1805a2e60e26b65c249c8ed
https://doi.org/10.1101/2022.10.03.507132
https://doi.org/10.1101/2022.10.03.507132
Publikováno v:
Biotechnology and bioengineeringREFERENCES. 118(9)
This article presents a systematic approach to evaluate the business case for continuous processing that captures trade-offs between manufacturing and development costs for monoclonal antibodies (mAbs). A decisional tool was built that integrated cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7d5c222f26dcd357be5ba3e6a2090b
https://pubmed.ncbi.nlm.nih.gov/33792918
https://pubmed.ncbi.nlm.nih.gov/33792918